Global Veterinary Biologics Market
The global veterinary biologicsmarket is estimated to be worth over USD22,772.71 Mn in 2033 and is expected to grow at CAGR of 6.3% during the forecast period (2024-2033).
The global veterinary biologics market is witnessingrobust growth, fuelled by different driving factors and presenting numerous opportunities for expansion. Major drivers comprise the growing demand for animal-derived products, led by growing global populations and incomes, which requires effective disease prevention in livestock and companion animals. In addition to that, the rise in pet ownership and the surging trend of pet humanization are boosting demand for advanced veterinary biologics to ensure the well-being of companion animals.
Significant opportunities lie in the incorporation of digital technologies such as telemedicineand electronic health records, which align animal health management and expand access to veterinary care. Along with that, breakthroughs in biotechnology, comprising recombinant DNA technology and gene editing, are transforming the development of novel vaccines and therapeutics, offering enhanced efficacy and safety. Strategic collaborations between stakeholders and initiatives aimed at eradicating diseases further propel market growth. Key developments comprise the surge of personalized veterinary medicine, tailoring treatments to individual animals, and the expansion of preventive healthcare programs, emphasizing vaccination and proactive disease management.
Overall, the global veterinary biologics market stands ready for continued expansion, fuelled by technological advancements, growing demand for animal health products, and a escalated focus on animal welfare and food safety.
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market report includes:
A preface providing an introduction to the full report, Veterinary Biologics market, 2023-2033.
An outline of the systematic research methodology adopted to conduct the study on Veterinary Biologics market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
An overview of economic factors that impact the overall Veterinary Biologics market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
An executive summary of the insights captured during our research, offering a high-level view of the current state of the Veterinary Biologics market and its likely evolution in the mid-to-long term.
A brief introduction to the Veterinary Biologics , highlighting their historical background, as well as information on their types, key aspects, key challenges and the advantages of using Veterinary Biologics.
A detailed assessment of the market landscape of Veterinary Biologics that are either approved or being evaluated in different stages of development, based on several relevant parameters, such as By Product (Vaccines, Bacterial Extracts, Monoclonal Antibody, Immunomodulatory {Cytokines, Others}, Allergenic Extracts), By Animals (Companion Animals {Canine, Avian, Feline}, Livestock Animals {Aquatic, Bovine, Porcine, Ovine/Caprine, Poultry}, Equine), By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Retail Pharmacies). Further, the chapter features analysis on key niche market segments. In addition, the chapter features analysis of various Veterinary Biologics developers, based on their year of establishment, company size, location of headquarters and most active players.
An in-depth analysis of partnerships and collaborations that have been inked between various stakeholders, since 2019, based on several relevant parameters, such as the year of partnership, type of partnership, focus of partnership, purpose of partnership, therapeutic applications and most active players (in terms of number of partnerships). It also highlights the regional distribution of partnership activity in this market.
A detailed analysis of various investments made by companies engaged in this industry, since 2019, based on several relevant parameters, such as year of funding, type of funding (grants, seed, venture capital, initial public offering, secondary offerings, private equity and debt financing), type of HPAPIs, amount invested, geography, purpose of funding, stage of development, therapeutic area, most active players (in terms of number and amount of funding instances) and leading investors (in terms of number of funding instances).
An in-depth analysis of the various Veterinary Biologics focused initiatives undertaken by big market players, based on several relevant parameters, such as number of initiatives, year of initiative, type of initiative, purpose of initiative, focus of initiative and location of headquarters of the big pharma players.
One of the key objectives of this market report was to estimate the current market size and the future growth potential of the Veterinary Biologics over the forecast period. Based on several parameters, such as regional analysis as well as segmental analysis rates, we have developed informed estimates of the likely evolution of the Veterinary Biologics market over the forecast period 2023-2033. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as By Product (Vaccines, Bacterial Extracts, Monoclonal Antibody, Immunomodulatory {Cytokines, Others}, Allergenic Extracts), By Animals (Companion Animals {Canine, Avian, Feline}, Livestock Animals {Aquatic, Bovine, Porcine, Ovine/Caprine, Poultry}, Equine), By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Retail Pharmacies), by key geographical regions (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) and leading players. In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.